The University of Chicago Header Logo

Connection

Matthew Koshy to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Matthew Koshy has written about Lung Neoplasms.
Matthew Koshy
Connection Strength
5.378
Lung Neoplasms
  1. Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC. Clin Lung Cancer. 2023 01; 24(1):60-71.
    View in: PubMed
    Score: 0.362
  2. Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States. Clin Lung Cancer. 2022 03; 23(2):151-158.
    View in: PubMed
    Score: 0.342
  3. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis. Lung Cancer. 2019 04; 130:162-168.
    View in: PubMed
    Score: 0.283
  4. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiat Oncol. 2019 Jan 28; 14(1):18.
    View in: PubMed
    Score: 0.281
  5. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy. Lung Cancer. 2017 06; 108:222-227.
    View in: PubMed
    Score: 0.249
  6. Response. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.228
  7. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer. J Natl Cancer Inst. 2015 Dec; 107(12):djv278.
    View in: PubMed
    Score: 0.223
  8. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):374-82.
    View in: PubMed
    Score: 0.221
  9. In Reply to Levy et al. Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):946-7.
    View in: PubMed
    Score: 0.220
  10. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
    View in: PubMed
    Score: 0.216
  11. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer. 2015 Jun; 88(3):267-74.
    View in: PubMed
    Score: 0.215
  12. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):344-50.
    View in: PubMed
    Score: 0.213
  13. Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother Oncol. 2015 Feb; 114(2):148-54.
    View in: PubMed
    Score: 0.212
  14. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71.
    View in: PubMed
    Score: 0.204
  15. In response. J Thorac Oncol. 2013 Nov; 8(11):e101.
    View in: PubMed
    Score: 0.196
  16. In response. J Thorac Oncol. 2013 Nov; 8(11):e99-100.
    View in: PubMed
    Score: 0.196
  17. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
    View in: PubMed
    Score: 0.191
  18. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J Thorac Oncol. 2013 Feb; 8(2):147-51.
    View in: PubMed
    Score: 0.186
  19. Is computed tomography simulation associated with improved survival, or is this finding a result of confounding variables? J Clin Oncol. 2011 Sep 10; 29(26):3587; author reply 3587-8.
    View in: PubMed
    Score: 0.168
  20. Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1388-94.
    View in: PubMed
    Score: 0.154
  21. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Chest. 2022 01; 161(1):248-256.
    View in: PubMed
    Score: 0.083
  22. Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head Neck. 2021 09; 43(9):2589-2601.
    View in: PubMed
    Score: 0.082
  23. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. J Thorac Oncol. 2020 11; 15(11):1738-1747.
    View in: PubMed
    Score: 0.078
  24. Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial. JAMA Oncol. 2018 09 01; 4(9):1291-1293.
    View in: PubMed
    Score: 0.068
  25. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Ann Surg Oncol. 2018 Jul; 25(7):2018-2026.
    View in: PubMed
    Score: 0.067
  26. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Pract Radiat Oncol. 2018 Jul - Aug; 8(4):245-250.
    View in: PubMed
    Score: 0.066
  27. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer. Lung Cancer. 2018 06; 120:88-90.
    View in: PubMed
    Score: 0.066
  28. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 03 01; 36(7):642-651.
    View in: PubMed
    Score: 0.066
  29. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
    View in: PubMed
    Score: 0.064
  30. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
    View in: PubMed
    Score: 0.059
  31. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. Cancer Med. 2015 Apr; 4(4):513-8.
    View in: PubMed
    Score: 0.053
  32. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Cancer. 2014 Jul 01; 120(13):2060-8.
    View in: PubMed
    Score: 0.050
  33. A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals. Med Phys. 2015 Aug; 42(8):4629-35.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.